Date/Time
Date(s) - 17/12/2020
9:00 am - 4:30 pm
Venue: Online Event
Registration: https://bit.ly/37HszLx | ZOOM Link: https://bit.ly/3gsQqm3
Which are the boundaries of healthcare and clinical research?
Clinical research involves studies of new drugs and interventions, in which patient subjects, volunteer, to receive a new or standard treatment for a predefined period of time and provide their outcomes for evaluation, under a strict, ethically cleared, protocol process. On the other hand, the healthcare sector provides medical services to patients on regular or acute follow-up visits. Both sectors are facing major disruptions due to the increasing need for several reasons to offer virtual services. And this is where Digital Therapeutic comes in, as the new kid on the block, to promise continuous monitoring of patients and offer digital therapeutics instead of standard therapeutic methods or as an addon.
A patient receiving standard of medical care treatment or a new promising treatment and has his outcomes constantly evaluated, is he not receiving medical care by a healthcare professional? Knowledge and insights coming from evaluation of treatments is becoming a necessity in both sectors and it has given birth to a new DTx era consuming insights to offer treatment.
In the previous editions of the iSprint workshops, we have addressed in #Sprint3 how AI mechanics are applied in the clinical research domain and in #Sprint2 the regulatory challenges of eHealth solutions seen as medical devices for clinical care. This year’s Sprint workshop will focus on how to bridge the silos of Clinical Research & eHealth and the emerging Digital Therapeutics, with a common goal: to offer patient-centric treatments of high efficacy. For this purpose, speakers from the medical and clinical industry, as well as regulators and policy makers will present their views, on how these domains are coming closer together.
Program
09.30 Welcome notes by Sofoklis Kyriazakos, CEO, Innovation Sprint
09.45 Vincenzo Bartoli, Senior VP, AstraZeneca – “Why the patients’ digital experience will drive the next wave of innovation in pharma”
10.15 Michelle Longmire, CEO, MEDABLE – “Virtual Clinical Trials”
10.30 Simon Bourne, CEO, my mHealth Ltd – “myCOPD the world’s first Digital Therapeutic for patients with Chronic Obstructive Pulmonary Disease”
Track I – Clinical Research & Digital Biotech
11.00 Konstantina Kostopoulou, Chief Product Officer, Innovation Sprint – “Healthentia Digital Biotech”
11.20 Olivier Schmidt, VP Sales Life Science, KEYRUS – “Leveraging Digital – Empathic Patient Experience within Clinical Trials”
11.40 Alan Yeomans, New Technologies WG leader, EUCROF – ‟The EUCROF New Technologies Working Group”
12.00 David Coman, CEO, Science 37 – ‟Increasing Patient Access: The Rise of Decentralized Clinical Trials”
12.20 Kuldeep Singh Rajput, CEO, Biofourmis
12.40 Aristodemos Pnevmatikakis, Innovation Sprint and Harm op den Akker, RRD – ‟Hackathon Announcement”
13.10 Lunch
Track II – eHealth / DTx
14.00 Hermie Hermens, Full Professor, University of Twente – “Techmed eHealth House and the ecosystem for personalised health”
14.20 Giuseppe Recchia, CEO, daVinci Digital Therapeutics – “Digital Therapies – overcoming barriers to entry into medical practice”
14.40 Alexander Olbrechts, Business Group Leader Health Tech, mHealthBELGIUΜ – “mHealthBelgium, an introduction to mobile health apps in Belgium”
15.00 vCare – clinical context, Massimo Caprino, Physician, CCP – “The vCARE experience: a digital coach to enhance home rehabilitation”
15.15 vCare – eHealth / REHABILITY, Lucia Pannese, CEO, Imaginary – “REHABILITY: Gamifying Tele-Rehabilitation”
Panel discussion: Bridging the Silos
15.20 Moderator: Alfredo Cesario Medical Director, Co-founder, Innovation Sprint
- Vincenzo Palermo, Oncology Vice President, GSK Italy – “The need of medtech innovation in Cancer”
- Benedikt Van Nieuwenhove, President, BeCRO
- Sophie Lineart, Project Coordinator / MedTech Accelerator lifetech.brussels – “The MedTech Accelerator: Catalyst for (connected) medtech innovation and growth in Brussels”
- Serge Bodart, Chief Commercial Officer, IDDI and eCOA Independent Consultant – “eCOA for Clinical Research: What makes the process so complex?”
- Dimitris Athanasiou, Member of PDCO EMA, Board Member of EPF and WDO – “Challenges and Opportunities for Patient Organizations in the Digital Era: The Duchenne Example”
16.00 End of workshop